Willington, United Kingdom

Ian Edward Smith

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Edward Smith. Retrieved from https://idiyas.com/inventor/ian-edward-smith-vmyjvw99

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Edward Smith: A Pioneer in Pharmaceutical Innovation

Introduction

Ian Edward Smith, an inventive mind based in Willington, Great Britain, has made his mark in the pharmaceutical industry with significant advancements in the realm of protein kinase inhibitors. With a single patent to his name, he has demonstrated the potential of innovative chemical compounds to address complex health issues.

Latest Patents

Smith’s notable patent, titled “Bicyclic nitrogen heterocycles - Amino-substituted dihydropyrimido[4,5-d]pyrimidinones,” showcases a complex formula capable of yielding numerous derivatives. This invention is particularly notable for its application in the treatment and prevention of various disorders, including inflammatory, immunological, oncological, bronchopulmonary, dermatological, and cardiovascular conditions. Notably, these compounds show promise in the treatment of asthma, central nervous system disorders, diabetic complications, and in the prevention of graft rejection following transplant surgery.

Career Highlights

Ian Edward Smith is currently affiliated with Hoffmann-La Roche Inc., a leading global healthcare company specializing in pharmaceuticals and diagnostics. His position there allows him to contribute to groundbreaking research and development efforts, emphasizing innovative solutions in the medical field.

Collaborations

To enhance his research and development endeavors, Smith collaborates with esteemed colleagues William Harris and Christopher H. Hill. Together, they work towards advancing their understanding of protein kinase inhibitors and their potential therapeutic applications, further strengthening Smith's impact on the scientific community.

Conclusion

Ian Edward Smith is a remarkable inventor contributing to significant advancements in pharmaceutical innovations. His work with protein kinase inhibitors exemplifies the critical role of inventors in addressing pressing health issues through innovative solutions. As he continues to develop and refine his research, the potential benefits of his inventions could lead to transformative changes in treatment methodologies, impacting countless lives around the globe.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…